GlassScriptPhysician profile
Corey J Krenz
NPI 1417682295
$3,702.59
in general payments reported to CMS, 2019-2025
41 companies · $1,285 in 2025
The $1,285 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $672 · 2023: $980 · 2024: $765 · 2025: $1,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,030.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $443.89 | 2022-2025 | |
| Astellas Pharma US INC | $311.31 | 2022-2025 | Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $293.92 | 2022-2025 | |
| Janssen Biotech, INC. | $286.76 | 2022-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $214.14 | 2023-2025 | Orgovyx, Gemtesa |
| Merck Sharp & Dohme LLC | $178.82 | 2022-2025 | Keytruda, Lynparza |
| Pfizer INC. | $151.04 | 2022-2025 | |
| Progenics Pharmaceuticals, INC. | $148.07 | 2022-2024 | Pylarify |
| Urogen Pharma, INC. | $136.82 | 2024-2025 | |
| Boston Scientific Corporation | $136.33 | 2022-2025 | Spaceoar Vue System - 10ml, Spaceoar System |
| Olympus America INC. | $131.70 | 2022-2025 | Itind System, Uretero-Reno Videoscope, Soltive |
| Accord Healthcare, INC. | $129.23 | 2022-2025 | |
| Endo USA, INC. | $125.00 | 2024-2025 | Xiaflex |
| Ferring Pharmaceuticals INC. | $117.49 | 2024-2025 | Adstiladrin |
| Teleflex LLC | $76.43 | 2023-2025 | Urolift, Deflux Metal Needle |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $72.64 | 2022-2023 | Gentlecath, Gentlecath Glide |
| Endo Pharmaceuticals INC. | $63.50 | 2023-2024 | Xiaflex, Aveed |
| Coloplast Corp | $60.77 | 2023-2025 | Porges Coloplast |
| Tolmar, INC. | $56.52 | 2023-2025 | Jatenzo, Eligard |
| Astrazeneca Pharmaceuticals LP | $47.93 | 2022-2023 | Lynparza |
| Myriad Genetic Laboratories, INC. | $39.47 | 2024-2025 | Prolaris |
| Karl Storz Endoscopy-America | $37.30 | 2023 | Flex-X |
| Telix Pharmaceuticals | $36.83 | 2023 | Illuccix |
| Azurity Pharmaceuticals, INC. | $36.42 | 2025 | Azmiro |
| Fresenius Kabi USA, LLC | $35.76 | 2025 | |
| Myovant Sciences INC. | $33.35 | 2022 | |
| Bioprotect Medical, INC. | $33.22 | 2025 | Bioprotect Balloon Implant System |
| Ambu INC. | $30.27 | 2024 | |
| Dendreon Pharmaceuticals LLC | $27.92 | 2025 | Provenge |
| Novartis Pharmaceuticals Corporation | $25.42 | 2022 | |
| Cycle Pharmaceuticals INC | $24.18 | 2025 | Venxxiva |
| Amgen INC. | $19.03 | 2023 | Prolia |
| Tolmar Pharmaceuticals, INC. | $18.59 | 2022 | |
| Procept Biorobotics Corporation | $18.37 | 2023 | Aquabeam Robotic System |
| Sagent Pharmaceuticals | $17.69 | 2024 | Glydo |
| Immunitybio, INC. | $17.09 | 2024 | |
| Photocure INC | $15.27 | 2023 | Cysview |
| Hollister Incorporated | $14.92 | 2022 | |
| Verity Pharmaceuticals INC. | $13.70 | 2025 | Trelstar |
| Laborie Medical Technologies Corp. | $13.48 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Krenz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.